Stock screener

RANI

Conviction 22HealthcareScan · Mon, Aug 10, 2026
Bearish engulfing
RANI$0.7820-1.26%
ResistanceSupportVol 14
63 bars
Vol MA14 1.1M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Rani Therapeutics Holdings, Inc.PHARMACEUTICAL PREPARATIONSwww.ranitherapeutics.com
Price0.7820
Change-1.26%
Gap+0.21%
Rel volume0.15×
Avg volume985.39K
Avg $ vol804.56K
SMA 200.7766
SMA 500.7792
SMA 2001.19
Price vs 50+0.35%
Price vs 200-34.32%
MA stackmixed
50/200 cross
Supertrendup · 0.6493
RSI (14)50
MACD hist0.00
MACD cross
Stoch %K / %D37 / 44
ADX (14)21
+DI / −DI23 / 18
RSI divergence
MACD divergence
ATR %+8.02%
ADR %8.63%
52w high2.85
52w low0.4582
From 52w high-72.56%
Above 52w low+70.67%
New 52w highNo
SqueezeOff
Bollinger width37.20%
%B0.52
Donchian pos47.40%
Donchian high0.9451
Donchian low0.6350
AVWAP (52w high)1.80
vs AVWAP high-56.48%
AVWAP (52w low)1.92
vs AVWAP low-59.24%
OBV trendUp
Chaikin MF (20)0.22
Today vs 20d0.15×
Avg vol (14d)1.1M
Avg vol (20d)985.39K
Avg $ vol (20d)804.56K
Market cap51.72K
RS 3m (vs SPY)-20.63%
RS 6m (vs SPY)-42.11%
RS line new highNo
Trend template3/8
Technical rank29.9
1 week-2.41%
1 month+13.80%
3 months-19.01%
6 months-35.90%
1 year+46.72%
YTD-42.50%
P/E-0.00
P/B0.00
P/S0.03
P/FCF-0.00
EPS-0.4500
Div yield
ROE-104.46%
ROA-57.20%
Debt/Eq0.00
Current3.40
EV/EBITDA
Gross margin
Net margin
Rev growth58.85%
EPS growth1.15%
Price target
Target upside
Analyst rating
Institutional
Ent. value-9.59M
Revenue1.71M
Net income-7.03M
Gross profit
Free cash flow-18.8M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out99.91M
Employees69
ListedFri, Jul 30, 2021
Free float73.33M
Float %75.2%
Short interest8.85M
Days to cover11.3d
Short volume66.7%
Squeeze score67 / 100
Next earnings
EPS forecast
Last EPS vs est−$0.04 vs −$0.06
Last surprise+33.3% beat
Setup gradeD
Conviction22 / 100
Pattern quality
Tech rank29.9 / 100
Group rank86 / 100 · Leading
Status lane
Setup direction
Pattern family
Resistance
Support
Days since event
Candle confirmBearish engulfing
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in RANI

All disclosures →
No recent disclosed trades by Congress in RANI. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in RANI · 9 buys

InsiderSideShares
Javadi Alireza
Chief Technical Officer · Stock Option (Right to Buy) · 2026-06-03
Grant805.5K
Imran Talat
Chief Executive Officer · Stock Option (Right to Buy) · 2026-06-03
Grant3.8M
McKinley Kate
Chief Business Officer · Stock Option (Right to Buy) · 2026-06-03
Grant805.5K
Bassan Abraham
Director · Director Stock Option (Right to Buy) · 2026-05-28
Grant123.6K
Bailey Vasudev Jaiprakash
Director · Director Stock Option (Right to Buy) · 2026-05-28
Grant123.6K
Rometty Lisa Ann
Director · Director Stock Option (Right to Buy) · 2026-05-28
Grant123.6K
BUTEL JEAN LUC
Director · Director Stock Option (Right to Buy) · 2026-05-28
Grant123.6K
Ausiello Dennis A
Director · Director Stock Option (Right to Buy) · 2026-05-28
Grant123.6K
IMRAN MIR A
Director · Director Stock Option (Right to Buy) · 2026-05-28
Grant123.6K

SEC filings

EDGAR filings in RANI · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.